SCHEMBL21920774

SCHEMBL21920774

Cc1cnn([C@H]2CCCNc3ncc(Br)c(Cl)c3C2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28604936 0.72 MAP4K1 (0.33) —
SCHEMBL21921477 0.72 MAP4K1 (0.33) —
SCHEMBL30087894 0.72 MAP4K1 (0.33) —
SCHEMBL28611842 0.70 MAP4K1 (0.34) —
SCHEMBL30088100 0.70 MAP4K1 (0.34) —
SCHEMBL21921376 0.70 NNMT (0.41) —
SCHEMBL16196568 0.68 NNMT (0.45) —
SCHEMBL13465804 0.66 ACHE (0.47) —
SCHEMBL13432197 0.66 OGA (0.45) —
SCHEMBL2600281 0.66 JAK2 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020061377-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2020-03-26 — — WO disclosed
Send feedback